Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
ACS Omega|January 17, 2022
Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer TherapyZhiyang Cheng, Ying Huang, Pingxuan Shao, et al.European Journal of Medicinal Chemistry|September 25, 2024
Synthesis and evaluation of homocamptothecin antibody-drug conjugates for cancer treatmentYalong Li, Zhiyang Cheng, Wei Zhou, et al.Journal of Medicinal Chemistry|December 15, 2025
Design and Evaluation of a Folate-Targeted PEG-MMAE Conjugate with Enzyme-Activated Drug Release for Enhanced Tumor Selectivity and Antitumor EfficacyLizhe Bai, Xuzhuo Li, Chengyi Zuo, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2026
β-glucuronidase-triggered ortho-hydroxyl-mediated cyclization strategy for the efficient delivery of phenolic payloads in antibody-drug conjugatesTaiwen Chen, Ziyue Cui, Qingling Miao, et al.Bioorganic Chemistry|May 31, 2026
NH2-trimethyl lock (NH2-TML): a stable and effective adapter for exatecan-based antibody-drug conjugatesXuzhuo Li, Lizhe Bai, Xiaomei Li, et al.ACS Pharmacology & Translational Science|March 19, 2026
Cathepsin B‑Responsive Phosphatidylinositol 3‑Kinase (PI3K) Prodrug for the Treatment of Pulmonary FibrosisXiaomei Li, Tao Yang, Shuyue Lei, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2025
Long-circulating enzyme-activated HSP90-targeted camptothecin derivativesMengyuan Ding, Qianqian Shen, Yi Su, et al.Molecules (Basel, Switzerland)|December 10, 2021
Design, Synthesis, and Biological Evaluation of HDAC Degraders with CRBN E3 Ligase LigandsYingxin Lu, Danwen Sun, Donghuai Xiao, et al.Journal of Materials Chemistry. B|February 11, 2020
Optimized HSP90 mediated fluorescent probes for cancer-specific bioimagingShulei Zhu, Yalei Li, Yushu Huang, et al.Bioorganic & Medicinal Chemistry|December 23, 2022
Design, synthesis, and biological evaluation of BRD4 degradersMengyuan Ding, Yingying Shao, Danwen Sun, et al.Pageof 4